Item 2.01
Completion of Acquisition or Disposition of Assets.
Sale of Wholly-Owned Subsidiary
On October 18, 2018, Mount Tam Biotechnologies, Inc., a Nevada corporation (the Company), and its wholly-owned subsidiary, Mount Tam Biotechnologies, Inc., a Delaware corporation (the Subsidiary) entered into a stock purchase agreement (the SPA) with ARJ Consulting, LLC, a New York limited liability company (the Buyer), pursuant to which the Company sold 100% of the capital stock in and of Subsidiary to the Buyer (the Sale Transaction). Prior to the Sale Transaction, the Company caused Subsidiary to transfer certain assets and a key license that Subsidiary was holding to another wholly-owned subsidiary of the Company, Mount Tam Therapeutics, Inc., a Delaware corporation. At the time of the Sale Transaction Subsidiary possessed certain Net Operating Losses and tax credits. Pursuant to the terms of the SPA, the Buyer purchased Subsidiary for a purchase price of $410,000.
The foregoing description of the sale of Subsidiary does not purport to be complete and is qualified in its entirety by reference to the actual terms and conditions of the SPA, a copy of which is being filed as Exhibit 10.1 hereto, and is incorporated herein by reference.
